Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
---|
10/21/2003 | US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
10/21/2003 | US6635266 For warding off the animals such as deer and geese from a vegetated area |
10/16/2003 | WO2003085072A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
10/16/2003 | WO2003084945A1 An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor |
10/16/2003 | WO2003084559A1 Vaccinium species compositions with novel beneficial properties |
10/16/2003 | WO2003084558A1 Improved kavalactone profile |
10/16/2003 | WO2003084557A1 Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family |
10/16/2003 | WO2003084556A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
10/16/2003 | WO2003084555A1 Compositions for inhibiting fibrosis |
10/16/2003 | WO2003084553A1 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
10/16/2003 | WO2003084512A1 Oral delivery of a botanical |
10/16/2003 | WO2003084302A2 Anti-aging agent |
10/16/2003 | WO2003064407A3 Production of δ9 tetrahydrocannabinol |
10/16/2003 | WO2003047533A3 Composition for treating the surface of the skin |
10/16/2003 | WO2003045414A3 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections |
10/16/2003 | WO2003041679A3 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells |
10/16/2003 | US20030195186 Administration of a therapeutically effective amount of at least one acetylcholinesterase inhibitor |
10/16/2003 | US20030195178 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof |
10/16/2003 | US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs |
10/16/2003 | US20030195166 Comprises non-digestible carbohydrate (dietary/coconut endosperm fiber; fructooligosaccharides) for preventing pathogenic bacteria growth in the large intestine |
10/16/2003 | US20030194758 Methods for the identification of fungal glucose utilization inhibitors and antifungal agents |
10/16/2003 | US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders |
10/16/2003 | US20030194455 Whole Ground brassica juncea seedpods, which include seed with oils intact, seed hull or husk and stem material ground to a powder to control root invading nematodes and pathogenic fungi within the soil. |
10/16/2003 | US20030194454 Mineral oil, benzyl alcohol, citronellal, d-limonene, safflower oil, soybean oil, or sesame oil |
10/16/2003 | US20030194453 Dietary supplement |
10/16/2003 | US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof |
10/16/2003 | US20030194451 Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases |
10/16/2003 | US20030194449 Medicinal herbal extract carpediol for treating depression |
10/16/2003 | US20030194448 Oral rehydration composition |
10/16/2003 | US20030194439 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
10/16/2003 | US20030194435 In particular dry plant extracts, wherein the acid donor of the effervescent couple is a dried fruit juice with a natural acid pH, such as freeze-dried citrus fruit juice. |
10/16/2003 | US20030194413 Methods and compositions employing red rice fermentation products |
10/16/2003 | CA2519028A1 Vaccinium species compositions with novel beneficial properties |
10/16/2003 | CA2486480A1 Improved kavalactone profile |
10/16/2003 | CA2478934A1 Process for producing oil and fat composition containing hydrophobic components of glycyrrhiza |
10/15/2003 | EP1352653A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy |
10/15/2003 | EP1352645A1 Effervescent compositions containing dried fruit juices |
10/15/2003 | EP1352640A1 Compositions for retarding skin aging |
10/15/2003 | EP1352569A1 Foods containing young wheat leaf powder |
10/15/2003 | EP1351698A2 Herbal composition for angina pectoris, method to prepare same and uses thereof |
10/15/2003 | EP1351663A1 Cosmetic and/or pharmaceutical preparations |
10/15/2003 | EP1351662A1 Cosmetic and/or pharmaceutical preparations |
10/15/2003 | EP1351647A1 Compositions and methods for treating hyperpigmentation |
10/15/2003 | EP1351573A1 Methods for modulating tumor growth and metastasis |
10/15/2003 | EP1135103B1 Use of plant extracts with an anti-radical-type action and cosmetic or dermopharmaceutical composition comprising such extracts |
10/15/2003 | EP1001740B1 USE OF THE Rb 1 GINSENOSIDE FOR STIMULATING ELASTIN SYNTHESIS |
10/15/2003 | CN1449281A Medicaments for treating colics |
10/15/2003 | CN1449024A Erase scheme for non-volatile memory |
10/15/2003 | CN1448501A Process for producing a culture of antrodia camphorata and product obtained thereby |
10/15/2003 | CN1124134C Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preven |
10/15/2003 | CN1124133C Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and pre |
10/15/2003 | CA2381830A1 Compositions comprising thylakoids useful in the modulation of the inflammation process |
10/14/2003 | US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
10/14/2003 | US6632460 Treating angina pectoris, reducing the usage of nitroglycerin |
10/14/2003 | US6632459 For prophylaxis and therapy of diseases, infections |
10/14/2003 | US6632458 Food using γ-aminobutyric acid-enriched cruciferous plant |
10/14/2003 | US6632443 Water-soluble compositions of bioactive lipophilic compounds |
10/14/2003 | US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain |
10/14/2003 | US6632422 Antiperspirant and deodorant products and methods for their use |
10/14/2003 | CA2040001C Hypoallergenic wheat preparation, process for producing the same, and processed food including the same |
10/09/2003 | WO2003082345A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith |
10/09/2003 | WO2003082313A1 Co-beadlet of dha and rosemary and methods of use |
10/09/2003 | WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
10/09/2003 | WO2003082311A1 Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids |
10/09/2003 | WO2003082310A1 Composition and method for the treatment or prevention of il-1 mediated disorders |
10/09/2003 | WO2003082309A1 Composition comprising an extract of liriopsis tuber for protecting brain cells and improving memory |
10/09/2003 | WO2003082308A1 Drugs including anticancer agents and immunopotentiators and health foods and drinks |
10/09/2003 | WO2003082249A1 Co-beadlet of dha and rosemary and methods of use |
10/09/2003 | WO2003082199A2 Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents |
10/09/2003 | WO2003045328A3 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
10/09/2003 | WO2003024465A3 Use of extracts of the genus cimicifuga as organoselective medicines |
10/09/2003 | WO2003004040A8 Dietetic preparation with hypocholesterolemic activity |
10/09/2003 | WO2002021926A3 An antimicrobial composition |
10/09/2003 | US20030191180 Pharmaceutical compositions |
10/09/2003 | US20030191159 Antisecretory agents; antiulcer agents; adjust absorption |
10/09/2003 | US20030191080 Cardiovascular disorders; hypotensive agents |
10/09/2003 | US20030191076 Induction of immunology response; transgenic plant; measles |
10/09/2003 | US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs) |
10/09/2003 | US20030190381 Medical composition for balancing bodily processes |
10/09/2003 | US20030190380 Heating Aloe vera gel to 35-80 degrees C, adding 0.01-2.0% tocotrienol/tocopherol blend, cooling |
10/09/2003 | US20030190379 Dressing for treating burns |
10/09/2003 | US20030190378 Extract of processed Panax genus plant, the preparation method thereof, and compositions containing the same |
10/09/2003 | US20030190377 With enhanced pharmacological effects due to subsequent acid-or heat-treatment and bio-converting treatment such as lactic acid bacterial and intestinal bacterial fermenting; prevention or treatment of gastrointestinal diseases |
10/09/2003 | US20030190376 Anti-Aromatase composition |
10/09/2003 | US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
10/09/2003 | US20030190344 Animal feed or feed additive as performance enhancer or appetite enhancer for live stock |
10/09/2003 | US20030190327 Seaweed extract (from red macroalgae); storage stability |
10/09/2003 | US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings |
10/09/2003 | CA2480436A1 Composition comprising an extract of liriopsis tuber for protecting brain cells and improving memory |
10/09/2003 | CA2479915A1 Co-beadlet of dha and rosemary and methods of use |
10/09/2003 | CA2478154A1 Co-beadlet of dha and rosemary and methods of use |
10/08/2003 | EP1351252A1 Erase scheme for non-volatile memory |
10/08/2003 | EP1350517A1 Analogues of dipeptide citrullinylarginine and their dermatological use as care and treatment agents |
10/08/2003 | EP1350516A1 Compositions for preventing or ameliorating multiple risk factor syndromes |
10/08/2003 | EP1349579A1 IMPROVED SOLUBILITY AND DISPERSIBILITY BY EXPOSURE TO O x? |
10/08/2003 | EP1349561A2 Local use of essential oils for treating herpes labialis |
10/08/2003 | EP1349560A2 Black tea extract for prevention of disease |
10/08/2003 | EP1349559A1 Compositions for inducing secretion of insulin-like growth factor-1 |
10/08/2003 | EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
10/08/2003 | EP1349553A1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |